On Wednesday, in the course of current trade, Shares of Gannett Co Inc (NYSE:GCI), climbed 0.60%, and is now trading at $13.39.
Gannett Co., stated results of operations derived from the merged financial statements and accounting records of the Company’s former Parent and presented as if the Company were a separate entity.
Recent highlights comprise:
- Accomplished the spin from its former Parent, regular way trading commenced on June 29, 2015.
- Accomplished the acquisition of the remaining 59.4% in the Texas-New Mexico Newspaper Partnership in the U.S. and the acquisition of Romanes Media Group in the U.K., resulting in annual revenues of about $100 million over the next twelve months.
- Achieved 92 million unique domestic digital visitors, a 16% enhance over the preceding year.
- Raised cost reduction estimate from $57 million to $67 million. Target run-rate to be reached in first half of 2016.
- Hired high-profile digital and print advertising executive as Gannett’s first-ever Chief Revenue Officer.
- Declared first-ever dividend of $0.16 per share payable to shareholders of record as of September 4, 2015 and approved $150 million share buyback program.
Gannett Co., Inc. operates as a multi-platform news and information company. Its operations comprise 100 daily publications and related digital platforms in the United States and the United Kingdom; and about 400 non-daily local publications in the United States and about 125 such titles in the United Kingdom.
During an Afternoon trade, Shares of United Therapeutics Corporation (NASDAQ:UTHR), climbed 0.44%, and is now trading at $166.69.
United Therapeutics Corporation, declared its financial results for the second quarter ended June 30, 2015.
“Orenitram sales grew nearly 300% as contrast to the second quarter of 2014 when the product was first launched,” said Roger Jeffs, Ph.D., United Therapeutics’ President and Co-Chief Executive Officer. “The growth in Orenitram sales was due to an enhance in the number of patients being treated, which strengthens our belief in the organic growth opportunity of our orally-administered prostacyclin analogue.”
United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide.
Shares of Flowserve Corp (NYSE:FLS), during its Wednesday’s current trading session gained 2.00%, and is now trading at $46.91.
Flowserve Corporation, declared a new planned agreement with United Valve of Houston, Texas, providing factory-authorized repair and service on Edward valves. The scope of the agreement between Flowserve and United Valve comprises authorized valve repair, valve modification and other opportunities as directed by Flowserve. The agreement with United Valve, a 54-year-old valve service company, will provide Edward valve customers an outlet for approved valve service work outside of the Flowserve Raleigh, North Carolina, location, specifically in the refining and petrochemical-rich Gulf Coast area of the United States. The Flowserve Edward valve product line is a world leader in providing multi-turn flow control solutions for nuclear and commercial power, petrochemical and refining industries worldwide.
Flowserve Corporation designs, manufactures, distributes, and services industrial flow administration equipment worldwide. The company operates through three segments: Engineered Product Division (EPD), Industrial Product Division (IPD), and Flow Control Division (FCD).
Finally, NetScout Systems, Inc. (NASDAQ:NTCT) , gain 0.21% at $ 37.42.
NetScout Systems, declared that it will host an event for sell-side analysts and institutional investors on Tuesday, August 4, 2015 in New York City. NetScout’s senior administration will outline the Company’s strategy, value proposition and growth opportunities in addition to provide additional insight into its near-term and longer-term financial outlook. Attendance is by invitation only.
NetScout Systems, Inc., together with its auxiliaries, designs, develops, manufactures, markets, licenses, sells, and supports network, application, and service assurance solutions in the United States, Europe, Asia, and internationally. It offers performance analytics and operational intelligence solutions that facilitate the evolution toward new computing paradigms, such as virtualization, mobility, and cloud.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
